
Vol. 5, No. 4-5, 2005
Free Abstract
Article (References)
Article (PDF 226 KB)
Free Access
Case Report
Pseudomyxoma Peritonei Accompanied by Intraductal Papillary Mucinous Neoplasm of the Pancreas
Yohei Mizutaa, Yuko Akazawaa, Ken Shiozawaa, Hiroshi Oharaa, Kazuo Ohbaa, Ken Ohnitaa, Hajime Isomotoa, Fuminao Takeshimaa, Katsuhisa Omagaria, Kenji Tanakab, Tohru Yasutakeb, Tohru Nakagoeb, Kenji Shironoc, Shigeru Kohnoa
aSecond Department of Internal Medicine, and bFirst Department of Surgery, Nagasaki University School of Medicine, cDepartment of Internal Medicine, Shimabara Hospital, Nagasaki, Japan
Address of Corresponding Author
Pancreatology 2005;5:470-474 (DOI: 10.1159/000086551)
Key Words
- Intraductal papillary mucinous neoplasm
- Intraperitoneal hyperthermic chemoperfusion
- Pseudomyxoma peritonei
Abstract
We describe a case ofpseudomyxoma peritonei (PMP) successfully managed with intraperitoneal hyperthermic chemoperfusion. This case is unique due to the concurrent presence of intraductal papillary mucinous neoplasm (IPMN) of the pancreas. The patient presented with abdominal fullness. Abdominal computed tomography revealed massive ascites, thickened peritoneum, and a cystic lesion of the pancreas. Cytological examination of ascitic fluid sample showed mucin-rich atypical cells. Endoscopic retrograde pancreatography revealed a cystic lesion with the defect probably due to mural nodule and mucin, communicating with the pancreatic duct. At exploratory laparotomy, massive ascites and multiple nodules were identified within the peritoneal cavity. No primary tumour, including mucinous neoplasm of the appendix, was found. Histopathological examination of the omentum showed mucinous adenocarcinoma in pools of mucoid material, consistent with PMP. The relation between PMP and IPMN of the pancreas was possible, but not conclusive. The patient received intraperitoneal perfusion of saline heated to 42°C containing cisplatin, etoposide, and mitomycin C, followed by 24 courses of postoperative chemotherapy with gemcitabine. The patient remains in good general condition with no signs of progression of PMP for 2 years, but with a gradual and progressive enlargement of the pancreatic cystic lesion. Copyright © 2005 S. Karger AG, Basel and IAP
Author Contacts
Yohei Mizuta, MD Second Department of Internal Medicine Nagasaki University School of Medicine 1-7-1, Sakamoto, Nagasaki 852-8501 (Japan) Tel. +81 95 849 7273, Fax +81 95 849 7285, E-Mail ymizuta@net.nagasaki-u.ac.jp
Article Information
Published online: June 27, 2005
Number of Print Pages : 5
Number of Figures : 4, Number of Tables : 1, Number of References : 19 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|